Hannah Zierden’s Post

Join us in December for back-to-back episodes of Sounds of Science as we explore the advancements in pre-exposure prophylaxis (PrEP) treatments and how new alternative methods can revolutionize drug discovery and development. https://okt.to/Gm6wR8

Join us in December for back-to-back episodes of Sounds of Science as we explore the advancements in pre-exposure prophylaxis (PrEP) treatments and how new alternative methods can revolutionize drug discovery and development. https://okt.to/k9N2CE

Join us in December for back-to-back episodes of Sounds of Science as we explore the advancements in pre-exposure prophylaxis (PrEP) treatments and how new alternative methods can revolutionize drug discovery and development. https://okt.to/H7QLBf

Join us in December for back-to-back episodes of Sounds of Science as we explore the advancements in pre-exposure prophylaxis (PrEP) treatments and how new alternative methods can revolutionize drug discovery and development. https://okt.to/pK9FC7

Join us in December for back-to-back episodes of Sounds of Science as we explore the advancements in pre-exposure prophylaxis (PrEP) treatments and how new alternative methods can revolutionize drug discovery and development. https://okt.to/7hmk1P

Join us in December for back-to-back episodes of Sounds of Science as we explore the advancements in pre-exposure prophylaxis (PrEP) treatments and how new alternative methods can revolutionize drug discovery and development. https://okt.to/1RiByz

"With the right design you can do fewer experiments and end up with the same results." Marie GERUS-DURAND explains how moving from one-factor-at-a-time experiments to modern multifactor DOE significantly accelerated the development of clinical trial protocols. At Cerba Research, this shift has enabled faster, high-quality results for clients. Learn more about how DOE can optimize processes: https://go.jmp/3XSADVg #JMP #TimeToInnovate #ClinicalTrials #pharma #designofexperiments

New to small molecule microarrays? Our article in IBI Journal gives an accessible overview of their history, process, and drug discovery applications. Read the full text here » https://lnkd.in/eVU9XttQ #highthroughputscreening #smallmolecule #drugdiscovery #microarray Arrayjet authors: Adam Buckle, Iain McWilliam, Julia Stefanie Renate Unsicker.

What does computation-driven drug discovery look like in Figure 1 of a manuscript describing, you guessed it, computation-driven drug discovery, in this case of molecular glue degraders? Note: more detail on the manuscript in an upcoming post. A bioRxiv view of Atommap.

📢 We are thrilled to share our latest publication:   "The development of a novel high-throughput membrane potential assay and a solid-supported membrane (SSM)-based electrophysiological assay to study the pharmacological inhibition of GLUT9/SLC2A9 isoforms in a drug discovery program".   This work introduces innovative methodologies to investigate the pharmacological modulation of GLUT9/SLC2A9 isoforms, key players in urate transport and metabolic disorders. By combining a high-throughput membrane potential assay with an SSM-based electrophysiological approach, we’ve created robust tools for advancing drug discovery efforts in this area.   A huge thank you to the incredible team behind this achievement! 🙌   📖 Read the full paper here: https://lnkd.in/ehYqssMv   Let’s continue to push the boundaries of innovation in drug discovery!   #DrugDiscovery #HTS #MembranePotential #Innovation #Science